SVRA
Savara Inc
NASDAQ: SVRA · HEALTHCARE · BIOTECHNOLOGY
$5.12
-3.96% today
Updated 2026-06-05
Market cap
$1.23B
P/E ratio
—
P/S ratio
145,272.62x
EPS (TTM)
$-0.56
Dividend yield
—
52W range
$2 – $7
Volume
1.5M
Savara Inc (SVRA) Insider transactions
Net insider activity
Net buying (3,728,854 shares)
Buy transactions
53
Sell transactions
47
All transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-03-18 | LOWRANCE, DAVID L | Chief Financial Officer | Sale | 130,650 | — | — |
| 2026-03-18 | LOWRANCE, DAVID L | Chief Financial Officer | Sale | 80,684 | — | — |
| 2026-03-18 | LOWRANCE, DAVID L | Chief Financial Officer | Sale | 75,000 | — | — |
| 2026-03-18 | LOWRANCE, DAVID L | Chief Financial Officer | Sale | 43,063 | — | — |
| 2026-03-18 | LOWRANCE, DAVID L | Chief Financial Officer | Sale | 24,850 | — | — |
| 2026-03-18 | LOWRANCE, DAVID L | Chief Financial Officer | Sale | 12,500 | — | — |
| 2026-03-18 | LOWRANCE, DAVID L | Chief Financial Officer | Buy | 130,650 | $1.23 | $160699.50 |
| 2026-03-18 | LOWRANCE, DAVID L | Chief Financial Officer | Buy | 80,684 | $1.51 | $121832.84 |
| 2026-03-18 | LOWRANCE, DAVID L | Chief Financial Officer | Buy | 75,000 | $1.59 | $119250.00 |
| 2026-03-18 | LOWRANCE, DAVID L | Chief Financial Officer | Buy | 43,063 | $1.11 | $47799.93 |
| 2026-03-18 | LOWRANCE, DAVID L | Chief Financial Officer | Sale | 31,885 | $5.04 | $160700.40 |
| 2026-03-18 | LOWRANCE, DAVID L | Chief Financial Officer | Buy | 24,850 | $3.35 | $83247.50 |
| 2026-03-18 | LOWRANCE, DAVID L | Chief Financial Officer | Sale | 24,174 | $5.04 | $121836.96 |
| 2026-03-18 | LOWRANCE, DAVID L | Chief Financial Officer | Sale | 23,661 | $5.04 | $119251.44 |
| 2026-03-18 | LOWRANCE, DAVID L | Chief Financial Officer | Sale | 16,518 | $5.04 | $83250.72 |
| 2026-03-18 | LOWRANCE, DAVID L | Chief Financial Officer | Buy | 12,500 | $4.45 | $55625.00 |
| 2026-03-18 | LOWRANCE, DAVID L | Chief Financial Officer | Sale | 11,037 | $5.04 | $55626.48 |
| 2026-03-18 | LOWRANCE, DAVID L | Chief Financial Officer | Sale | 9,485 | $5.04 | $47804.40 |
| 2026-02-16 | MCCRACKEN, JOSEPH S | Director | Sale | 1,807 | — | — |
| 2026-02-16 | MCCRACKEN, JOSEPH S | Director | Buy | 1,807 | $1.76 | $3180.32 |
| 2025-12-19 | RAMSAY, DAVID A | Director | Sale | 20,000 | $6.06 | $121220.00 |
| 2025-12-16 | PAULS, MATTHEW | Director, CHIEF EXECUTIVE OFFICER | Sale | 128,995 | — | — |
| 2025-12-16 | LOWRANCE, DAVID L | Chief Financial Officer | Sale | 32,000 | — | — |
| 2025-12-14 | PAULS, MATTHEW | Director, CHIEF EXECUTIVE OFFICER | Sale | 195,705 | $6.92 | $1.35M |
| 2025-12-14 | MCCABE, KATHLEEN R. | Chief Legal Officer | Sale | 39,350 | $6.92 | $272302.00 |
| 2025-12-14 | LUTZ, ROBERT MATTHEW | Chief Operating Officer | Sale | 67,760 | $6.92 | $468899.20 |
| 2025-12-14 | LOWRANCE, DAVID L | Chief Financial Officer | Sale | 62,960 | $6.92 | $435683.20 |
| 2025-12-14 | ERICKSON, ANNE | Chief Business Officer | Sale | 62,960 | $6.92 | $435683.20 |
| 2025-12-10 | PAULS, MATTHEW | Director, CHIEF EXECUTIVE OFFICER | Sale | 23,629 | — | — |
| 2025-12-09 | VAN, ES-JOHANSSON AN | Director | Buy | 40,000 | — | — |
| 2025-12-09 | RAMSAY, DAVID A | Director | Buy | 40,000 | — | — |
| 2025-12-09 | MCCRACKEN, JOSEPH S | Director | Buy | 40,000 | — | — |
| 2025-12-09 | HAWKINS, RICHARD J | Director | Buy | 40,000 | — | — |
| 2025-12-09 | ELAM, NEVAN C | Director | Buy | 40,000 | — | — |
| 2025-12-04 | WASFI, YASMINE | Chief Medical Officer | Sale | 21,992 | $6.37 | $140089.04 |
| 2025-12-02 | ELAM, NEVAN C | Director | Sale | 5,860 | — | — |
| 2025-12-02 | ELAM, NEVAN C | Director | Buy | 5,860 | $1.46 | $8555.60 |
| 2025-12-02 | ELAM, NEVAN C | Director | Sale | 1,473 | $5.81 | $8558.13 |
| 2025-11-14 | HAWKINS, RICHARD J | Director | Sale | 5,860 | — | — |
| 2025-11-14 | HAWKINS, RICHARD J | Director | Buy | 5,860 | $1.46 | $8555.60 |
| 2025-10-20 | WASFI, YASMINE | Chief Medical Officer | Buy | 70,000 | — | — |
| 2025-10-20 | WASFI, YASMINE | Chief Medical Officer | Buy | 35,000 | — | — |
| 2025-06-20 | HAWKINS, RICHARD J | Director | Buy | 48,225 | $2.04 | $98571.90 |
| 2025-05-29 | MCCRACKEN, JOSEPH S | Director | Buy | 10,000 | $2.08 | $20825.00 |
| 2025-03-31 | RAMSAY, DAVID A | Director | Buy | 150,000 | $2.78 | $416250.00 |
| 2025-02-13 | LUTZ, ROBERT MATTHEW | Chief Operating Officer | Sale | 38,263 | $2.83 | $108284.29 |
| 2024-12-16 | PAULS, MATTHEW | Director, CHIEF EXECUTIVE OFFICER | Sale | 54,702 | $3.31 | $180828.40 |
| 2024-12-16 | LOWRANCE, DAVID L | Chief Financial Officer | Sale | 25,000 | $3.33 | $83277.50 |
| 2024-12-16 | HAWKINS, RICHARD J | Director | Sale | 8,000 | $3.32 | $26568.80 |
| 2024-12-13 | PAULS, MATTHEW | Director, CHIEF EXECUTIVE OFFICER | Sale | 92,593 | $3.21 | $297223.53 |
| 2024-12-13 | LOWRANCE, DAVID L | Chief Financial Officer | Sale | 24,350 | $3.21 | $78163.50 |
| 2024-12-13 | LOWRANCE, DAVID L | Chief Financial Officer | Sale | 12,000 | — | — |
| 2024-12-13 | ERICKSON, ANNE | Chief Business Officer | Sale | 18,263 | $3.21 | $58624.23 |
| 2024-12-12 | VAN, ES-JOHANSSON AN | Director | Buy | 40,000 | — | — |
| 2024-12-12 | RAMSAY, DAVID A | Director | Buy | 40,000 | — | — |
| 2024-12-12 | PRATT, RAYMOND DENNIS | Chief Medical Officer | Buy | 280,000 | — | — |
| 2024-12-12 | PRATT, RAYMOND DENNIS | Chief Medical Officer | Buy | 80,000 | — | — |
| 2024-12-12 | PAULS, MATTHEW | Director, CHIEF EXECUTIVE OFFICER | Buy | 900,000 | — | — |
| 2024-12-12 | PAULS, MATTHEW | Director, CHIEF EXECUTIVE OFFICER | Buy | 400,000 | — | — |
| 2024-12-12 | PARKER, BRADEN C. | Chief Commercial Officer | Buy | 40,000 | — | — |
| 2024-12-12 | PARKER, BRADEN C. | Chief Commercial Officer | Buy | 20,000 | — | — |
| 2024-12-12 | MCCRACKEN, JOSEPH S | Director | Buy | 40,000 | — | — |
| 2024-12-12 | LUTZ, ROBERT MATTHEW | Chief Operating Officer | Buy | 300,000 | — | — |
| 2024-12-12 | LUTZ, ROBERT MATTHEW | Chief Operating Officer | Buy | 100,000 | — | — |
| 2024-12-12 | LOWRANCE, DAVID L | Chief Financial Officer | Buy | 300,000 | — | — |
| 2024-12-12 | LOWRANCE, DAVID L | Chief Financial Officer | Buy | 100,000 | — | — |
| 2024-12-12 | HAWKINS, RICHARD J | Director | Buy | 40,000 | — | — |
| 2024-12-12 | ERICKSON, ANNE | Chief Business Officer | Buy | 300,000 | — | — |
| 2024-12-12 | ERICKSON, ANNE | Chief Business Officer | Buy | 100,000 | — | — |
| 2024-12-12 | ELAM, NEVAN C | Director | Buy | 40,000 | — | — |
| 2024-11-19 | MCCRACKEN, JOSEPH S | Director | Buy | 20,000 | $2.95 | $59072.00 |
| 2024-11-18 | RAMSAY, DAVID A | Director | Buy | 100,000 | $2.88 | $287600.00 |
| 2024-11-10 | PRATT, RAYMOND DENNIS | Chief Medical Officer | Sale | 49,950 | $3.97 | $198301.50 |
| 2024-10-21 | ERICKSON, ANNE | Chief Business Officer | Sale | 381 | $3.57 | $1360.17 |
| 2024-09-25 | PARKER, BRADEN C. | Chief Commercial Officer | Buy | 170,000 | — | — |
| 2024-09-25 | PARKER, BRADEN C. | Chief Commercial Officer | Buy | 85,000 | — | — |
| 2024-07-21 | ERICKSON, ANNE | Chief Business Officer | Sale | 381 | $4.47 | $1703.07 |
| 2024-04-21 | ERICKSON, ANNE | Chief Business Officer | Sale | 381 | $4.81 | $1832.61 |
| 2023-12-28 | PAULS, MATTHEW | Director, CHIEF EXECUTIVE OFFICER | Sale | 84,000 | $4.71 | $395900.40 |
| 2023-12-28 | PAULS, MATTHEW | Director, CHIEF EXECUTIVE OFFICER | Sale | 19,000 | — | — |
| 2023-12-28 | LOWRANCE, DAVID L | CHIEF FINANCIAL OFFICER | Sale | 10,000 | $4.71 | $47131.00 |
| 2023-12-28 | ELAM, NEVAN C | Director | Sale | 40,000 | — | — |
| 2023-12-28 | ELAM, NEVAN C | Director | Sale | 12,000 | — | — |
| 2023-12-28 | ELAM, NEVAN C | Director | Sale | 1,758 | — | — |
| 2023-12-28 | ELAM, NEVAN C | Director | Sale | 93,843 | $4.71 | $442291.44 |
| 2023-12-28 | ELAM, NEVAN C | Director | Buy | 40,000 | $1.23 | $49200.00 |
| 2023-12-28 | ELAM, NEVAN C | Director | Buy | 12,000 | $1.59 | $19080.00 |
| 2023-12-28 | ELAM, NEVAN C | Director | Buy | 1,758 | $0.82 | $1441.56 |
| 2023-12-15 | LOWRANCE, DAVID L | CHIEF FINANCIAL OFFICER | Sale | 20,000 | — | — |
| 2023-12-14 | VAN, ES-JOHANSSON AN | Director | Buy | 22,500 | — | — |
| 2023-12-14 | SUN, RICKY | Director | Buy | 22,500 | — | — |
| 2023-12-14 | RAMSAY, DAVID A | Director | Buy | 22,500 | — | — |
| 2023-12-14 | PRATT, RAYMOND DENNIS | Chief Medical Officer | Buy | 40,000 | — | — |
| 2023-12-14 | PRATT, RAYMOND DENNIS | Chief Medical Officer | Buy | 150,000 | — | — |
| 2023-12-14 | PAULS, MATTHEW | Director, CHIEF EXECUTIVE OFFICER | Buy | 225,000 | — | — |
| 2023-12-14 | PAULS, MATTHEW | Director, CHIEF EXECUTIVE OFFICER | Buy | 450,000 | — | — |
| 2023-12-14 | PAULS, MATTHEW | Director, CHIEF EXECUTIVE OFFICER | Sale | 109,680 | $4.45 | $488076.00 |
| 2023-12-14 | MCCRACKEN, JOSEPH S | Director | Buy | 22,500 | — | — |
| 2023-12-14 | LUTZ, ROBERT MATTHEW | Chief Operating Officer | Buy | 40,000 | — | — |
| 2023-12-14 | LUTZ, ROBERT MATTHEW | Chief Operating Officer | Buy | 160,000 | — | — |
Frequently asked questions
Are SVRA insiders buying or selling?
Over the transactions on record, SVRA insiders have been net buyers, with about $6.23M in stock sold across 47 sales, against 17 open-market purchases.
Does insider selling at SVRA mean the stock will fall?
Not by itself. Most executive selling is pre-scheduled through 10b5-1 plans filed months in advance, and insiders sell for diversification, taxes, and liquidity far more often than out of any view on the price. Insider buying is the stronger signal, especially when several insiders buy around the same time, because there is usually only one reason to put personal cash into the stock.
Which SVRA insiders are selling the most?
Recent selling is concentrated in a few names. PAULS, MATTHEW accounts for the largest share on record, with about $2.72M sold. Selling by one or two individuals matters less than broad selling across the whole leadership team, which is the pattern worth watching.